Pennsylvania drug diversion law
Statutes, board rules, penalties, reporting deadlines and monitoring, as read on 15 November 2026.
Pennsylvania's diversion framework rests on three acts and one regulatory chapter: the Pharmacy Act, which governs pharmacist discipline; The Controlled Substance, Drug, Device and Cosmetic Act, which defines the criminal offences; the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act, which creates the prescription monitoring database; and Chapter 27 of Title 49 of the Pennsylvania Code, which holds the State Board of Pharmacy's regulations. Each statement below links to the text it comes from.
Statutes: the Pharmacy Act and the Drug Act
Section 5 of the Pharmacy Act gives the State Board of Pharmacy the power to refuse, revoke or suspend a pharmacist's licence on proof satisfactory to it of specified grounds. They include a guilty plea, nolo contendere plea, probation without verdict or Accelerated Rehabilitative Disposition on felony charges, or a finding of guilt, for any offence in connection with the practice of pharmacy or any offence involving moral turpitude; being unfit to practise pharmacy because of intemperance in the use of alcoholic beverages, controlled substances or any other substance that impairs the intellect and judgment to the extent of impairing professional duties; and having violated or knowingly permitted the violation of any provision of the act or a regulation of the board [1].
The criminal offences are in section 13 of the Controlled Substance, Drug, Device and Cosmetic Act. Section 13(a)(12) prohibits the acquisition or obtaining of possession of a controlled substance by misrepresentation, fraud, forgery, deception or subterfuge [2]. The same subsection, at clause (28), prohibits furnishing false or fraudulent material information in, or omitting material information from, any application, report or other document required to be kept or filed under the act [2].
Section 23 of the Drug Act links criminal outcomes to licences. The appropriate licensing boards may revoke or suspend a practitioner's licence on proof that the licensee is dependent on the use of any controlled substance, and may revoke or suspend it when the practitioner has pleaded guilty or nolo contendere to, or been convicted of, a felony under the act or a similar State or Federal law [2].
Board regulations: Chapter 27
Section 27.71 of Title 49 makes the chapter enforceable through the licence: failure to comply with the chapter is grounds for revocation or suspension of licensure under section 5(a)(6) of the Pharmacy Act [3]. That means a breach of a security or recordkeeping rule can be charged as a disciplinary matter without proof of any theft.
The security rules are in sections 27.16 and 27.17. Section 27.17 requires Schedule II controlled substances to be stored in securely locked, substantially constructed cabinets, although they may be dispersed throughout the stock of noncontrolled substances in a manner that obstructs theft or diversion [4]. It also provides that the occasional entry of authorised personnel into an area where controlled substances are accessible is allowed only when a licensed pharmacist is present and supervising [4].
Accountability for those measures is assigned to the manager. Under section 27.17(c), the pharmacist manager is responsible for assuring that licensed persons, employees and others who enter the prescription area know and abide by the standards of security, and that other measures necessary to ensure their enforcement are taken [4]. Section 27.16 adds that the prescription area must contain a substantially constructed cabinet or safe for controlled substances, unless the pharmacy disperses them throughout the stock in a manner that obstructs theft [5].
Penalties: criminal, licence and civil
Section 13(f) of the Drug Act grades a violation of clause (12), the fraud-acquisition offence, by the substance. With respect to a Schedule I or II narcotic drug the person is guilty of a felony and is sentenced to imprisonment not exceeding fifteen years, or to pay a fine not exceeding $250,000, or both, or such larger amount as is sufficient to exhaust the assets used in and the profits obtained from the illegal activity [2]. Other schedules are graded in later paragraphs of the same subsection, which this page does not restate.
Licence consequences follow the conviction. Under section 23(b) a board may revoke or suspend after a felony plea or conviction, after a hearing. Under section 23(c) the boards must automatically suspend, for a period not to exceed one year, the licence of a practitioner who has pleaded guilty or nolo contendere to or been convicted of a misdemeanour under the act, and the district attorney of each county must immediately notify the licensing board [2]. The automatic suspension may be stayed where the violation was only for the practitioner's personal use and the practitioner participates in an approved impaired professional programme for three to five years [2].
The Pharmacy Act has its own penalties. A person who violates any provision of section 8, the unlawful acts section, commits a misdemeanour punishable by imprisonment of not more than one year or a fine of not more than $5,000, or both, and a subsequent offence by imprisonment of not more than three years or a fine of not more than $15,000, or both [1]. In addition, the board may levy a civil penalty of up to $1,000 on a current licensee who violates any provision of the act, after a hearing [1].
Reporting duties and deadlines
The clearest fixed deadline is for dispensing data. Section 7(c) of the ABC-MAP Act requires a dispenser or pharmacy to submit all required information to the system no later than the close of the subsequent business day after dispensing a controlled substance [6]. The data elements include the prescriber's name and DEA number, the dates written and dispensed, the patient's name, date of birth, gender and address, the National Drug Code, the quantity and days' supply, and the method of payment [6].
Section 3.2 of the Pharmacy Act requires a pharmacist who is also licensed in another state, territory or country to report any disciplinary action taken there to the board on the biennial registration application or within ninety days of final disposition, whichever is sooner [1].
None of the Pennsylvania statutes or Chapter 27 sections read for this page sets a numeric deadline for reporting a theft or loss of controlled substances to the board, so this page does not state one. Federal registrants have separate federal reporting obligations that are outside the scope of this page.
Monitoring: ABC-MAP and impaired-professional programmes
Section 7(e) of the ABC-MAP Act, added in 2016, requires a dispenser to query the system before dispensing an opioid drug product or a benzodiazepine prescribed to a patient if the patient is new to the dispenser, pays cash when they have insurance, requests a refill early, or is getting opioid drug products or benzodiazepines from more than one prescriber [6]. A dispenser may designate other pharmacy employees to access the system according to standards the board sets [6].
The Act also protects the data and penalises misuse. It is a misdemeanour of the first degree to knowingly or intentionally obtain information from the system for purposes other than those the Act specifies or by misrepresentation or fraud, and a felony of the third degree to release or sell that information for other purposes [6]. Knowing, intentional and negligent release or use of information from the system is subject to a civil penalty of not less than $2,500 for each offence, and a prescriber or dispenser violating the Act is also subject to sanctions under the professional practice act and by the appropriate licensing board [6].
For impaired licensees, section 23(c) of the Drug Act refers to the impaired professional programme approved by the appropriate licensing board and states that, if a participant fails to comply in all respects with the programme's standards, the board must immediately vacate the stay of suspension [2]. Section 5(a)(4) of the Pharmacy Act separately lets the board, on probable cause, compel a pharmacist to submit to a mental or physical examination, and requires that an affected pharmacist be afforded an opportunity at reasonable intervals to demonstrate that they can resume competent practice [1].
Sources
Each link below was fetched on 15 November 2026 and returned HTTP 200. Bracketed numbers in the text open the same pages.
- Pharmacy Act, Act of Sept. 27, 1961 (P.L. 1700, No. 699), 63 P.S. § 390-1 et seq., sections 3.2, 5 and 8
- The Controlled Substance, Drug, Device and Cosmetic Act, Act 64 of 1972, sections 13 and 23
- 49 Pa. Code § 27.71, Revocation and suspension
- 49 Pa. Code § 27.17, Security for Schedule II controlled substances
- 49 Pa. Code § 27.16, Construction and equipment requirements
- Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act, Act 191 of 2014, sections 7 and 10
Scope. This page summarises statutes and regulations as read in November 2026 and is not legal advice. It does not cover the Professional Nursing Law, the Department of Health's regulations, federal DEA requirements, or amendments enacted after the versions of the acts published on the General Assembly's site. Check the current text and the board's published guidance before relying on a deadline or penalty.
Related pages
- Documented diversion cases in Pennsylvania, with the state's licensing boards
- Reporting employee drug diversion: who to notify and in what order
- What diversion costs: penalties stated in the case records
- The other state law pages: California, Texas, Florida, New York, Ohio, Michigan, New Jersey, Illinois, Georgia
Would your controls meet these duties?
The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.
Start the free assessmentWould your controls meet these duties?
The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.
Start the free assessment